Oncodesign
FranceEntry
2022
Hold
4yr
Status
Active
Who owns Oncodesign?
Oncodesign is currently owned by Edmond de Rothschild Private Equity (France) through Edmond de Rothschild Equity Strategies IV (2023 vintage), since 2022. Across its history, Oncodesign has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Edmond de Rothschild Private Equity (France)Edmond de Rothschild Equity Strategies IV · 2023 · Buyout
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Crédit Mutuel Equity, Eurazeo, Elyan Partners and Edmond de Rothschild Private Equity (France) since 2008.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-held by Crédit Mutuel Equity, Eurazeo, Elyan Partners and Edmond de Rothschild Private Equity (France) since 2008.
Co-invest · 4 holders · 2008 · present
Crédit Mutuel EquityActive
2008 · present(18yr) · Crédit Mutuel Equity · 1992 · Growth
Elyan PartnersActive
2022 · present(4yr) · ERES IV · 2021 · Buyout
EurazeoActive
2022 · present(4yr) · Nov Sante Actions Non Cotees · 2020 · Healthcare
More from Edmond de Rothschild Equity Strategies IV
Other portfolio companies in the same fund.
Switzerland
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Oncodesign
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Oncodesign?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Oncodesign.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue